Elucidate + Diagnose
“Make clear” + “Identify the nature of a problem”
EluciDx provides an expansive view into the healthcare industry and develops innovative yet practical strategies based on years of hands-on entrepreneurship and experience as an industry executive.
Beyond consulting, EluciDx runs its own R&D programs in collaboration with leading universities — from novel Raman spectroscopy-based blood chemistry analysis with UBC Chemistry, to continuous flow API synthesis with UNBC Biochemistry, to a Phase 2-ready oral amphotericin B asset licensed from UBC.
James W. Kim
Founder & CEO
Ph.D. Biochemistry, UW-Madison
Former Executive Director & CEO of SciGen Inc. (Singapore), BD Director at Bioton S.A. (Warsaw) and Novotek Pharmaceuticals (Beijing). Started at LG Life Sciences in corporate Business Development and Diagnostics Planning. Co-founder of TKL Corporation. Advisor to Africa CDC.
Affiliates & Clients